These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

521 related items for PubMed ID: 8801396

  • 21. Efficacy of low-dose cholesterol-lowering drug therapy in men with moderate hypercholesterolemia.
    Denke MA, Grundy SM.
    Arch Intern Med; 1995 Feb 27; 155(4):393-9. PubMed ID: 7848022
    [Abstract] [Full Text] [Related]

  • 22. [Comparison between lovastatin and gemfibrozil in treatment of primary hyperlipidemias].
    Bertolami MC, Martinez TL, Faludi AA, Pinto LE, Melo RS, Bismarck ZF, Batlouni M.
    Arq Bras Cardiol; 1991 May 27; 56(5):407-12. PubMed ID: 1823741
    [Abstract] [Full Text] [Related]

  • 23. Comparison of gemfibrozil and lovastatin in patients with high low-density lipoprotein and low high-density lipoprotein cholesterol levels.
    McKenney JM, Barnett MD, Wright JT, Proctor JP.
    Arch Intern Med; 1992 Sep 27; 152(9):1781-7. PubMed ID: 1520045
    [Abstract] [Full Text] [Related]

  • 24. [Efficacy and tolerability of simvastatin and omega-3 fatty acid combination in patients with coronary disease, hypercholesterolemia and hypertriglyceridemia].
    Tomei R, Rossi L, Carbonieri E, Franceschini L, Cemin C, Ghebremariam-Tesfau K, Zardini P.
    Cardiologia; 1993 Dec 27; 38(12):773-8. PubMed ID: 8200011
    [Abstract] [Full Text] [Related]

  • 25. [Therapy of hypercholesterolemia and hypertriglyceridemia. Comparison of hypolipemic effects of lovastatin and gemfibrozil].
    Gavelli MS, Vitaliano E, Rossi FG, Serra T, Santini G, Bernardi G.
    Clin Ter; 1991 Jan 15; 136(1):31-8. PubMed ID: 1826871
    [Abstract] [Full Text] [Related]

  • 26. Effect of combination nicotinic acid and gemfibrozil treatment on intermediate density lipoprotein, and subclasses of low density lipoprotein and high density lipoprotein in patients with combined hyperlipidemia.
    Superko HR, Garrett BC, King SB, Momary KM, Chronos NA, Wood PD.
    Am J Cardiol; 2009 Feb 01; 103(3):387-92. PubMed ID: 19166694
    [Abstract] [Full Text] [Related]

  • 27. [The comparative treatment with lovastatin and bezafibrate of primary hypercholesterolemia. A randomized and double-blind trial].
    Sánchez Domínguez J, Rodríguez Padial L, Navarro A, Barcina C, Fernández E, Rivera G, Cuesta L, Lázaro-Carrasco E.
    Rev Esp Cardiol; 1991 Apr 01; 44(4):251-7. PubMed ID: 2068368
    [Abstract] [Full Text] [Related]

  • 28. Lipid-lowering effects of colesevelam HCl in combination with ezetimibe.
    Bays H, Rhyne J, Abby S, Lai YL, Jones M.
    Curr Med Res Opin; 2006 Nov 01; 22(11):2191-200. PubMed ID: 17076980
    [Abstract] [Full Text] [Related]

  • 29. Etofibrate therapy and effect of added low-dose cholestyramine in patients with combined hyperlipidaemia.
    Krüger B.
    Int J Clin Pharmacol Res; 1994 Nov 01; 14(5-6):177-83. PubMed ID: 7672874
    [Abstract] [Full Text] [Related]

  • 30. A multicenter, randomized, double-blind, placebo-controlled, factorial design study to evaluate the lipid-altering efficacy and safety profile of the ezetimibe/simvastatin tablet compared with ezetimibe and simvastatin monotherapy in patients with primary hypercholesterolemia.
    Bays HE, Ose L, Fraser N, Tribble DL, Quinto K, Reyes R, Johnson-Levonas AO, Sapre A, Donahue SR, Ezetimibe Study Group.
    Clin Ther; 2004 Nov 01; 26(11):1758-73. PubMed ID: 15639688
    [Abstract] [Full Text] [Related]

  • 31. Effects of simvastatin and cholestyramine in familial and nonfamilial hypercholesterolemia. Multicenter Group I.
    Stein E, Kreisberg R, Miller V, Mantell G, Washington L, Shapiro DR.
    Arch Intern Med; 1990 Feb 01; 150(2):341-5. PubMed ID: 2405804
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the lipid-modifying efficacy and safety profiles of ezetimibe coadministered with simvastatin in older versus younger patients with primary hypercholesterolemia: a post Hoc analysis of subpopulations from three pooled clinical trials.
    Feldman T, Davidson M, Shah A, Maccubbin D, Meehan A, Zakson M, Tribble D, Veltri E, Mitchel Y.
    Clin Ther; 2006 Jun 01; 28(6):849-59. PubMed ID: 16860168
    [Abstract] [Full Text] [Related]

  • 33. Effect of combining viscous fibre with lovastatin on serum lipids in normal human subjects.
    Agrawal AR, Tandon M, Sharma PL.
    Int J Clin Pract; 2007 Nov 01; 61(11):1812-8. PubMed ID: 17935545
    [Abstract] [Full Text] [Related]

  • 34. [Efficacy and safety of simvastatin, a new cholesterol-lowering drug].
    Mol MJ, Stuyt PM, Stalenhoef AF.
    Ned Tijdschr Geneeskd; 1989 Feb 18; 133(7):362-6. PubMed ID: 2927555
    [Abstract] [Full Text] [Related]

  • 35. [Long term treatment of moderate to severe hypercholesterolemia with low dose statin. Comparison of simvastatin and pravastatin].
    Spagnolli W, Ramponi C, Focher C, Dal Piaz A, Torboli P, Miori R, De Venuto G.
    Recenti Prog Med; 1996 Nov 18; 87(11):538-42. PubMed ID: 9122535
    [Abstract] [Full Text] [Related]

  • 36. [Cholestyramine in the treatment of hypercholesterolemia. Our experience in 11 cases].
    Maíz A, Arteaga A, Villanueva CL, Velasco N, Acosta AM.
    Rev Med Chil; 1990 Sep 18; 118(9):1009-13. PubMed ID: 2152729
    [Abstract] [Full Text] [Related]

  • 37. [Familial hypercholesterolemia--intensive diet therapy combined with drug therapy].
    Stugaard M, Wiig I, Lund H, Ose L, Norseth J.
    Tidsskr Nor Laegeforen; 1992 Aug 30; 112(20):2642-6. PubMed ID: 1412289
    [Abstract] [Full Text] [Related]

  • 38. Coadministration of valsartan 160 and 320 mg and simvastatin 20 and 40 mg in patients with hypertension and hypercholesterolemia: a multicenter, 12-week, double-blind, double-dummy, parallel-group superiority study.
    Rump LC, Baranova E, Okopien B, Weisskopf M, Kandra A, Ferber P.
    Clin Ther; 2008 Oct 30; 30(10):1782-93. PubMed ID: 19014834
    [Abstract] [Full Text] [Related]

  • 39. Helsinki Heart Study: primary-prevention trial with gemfibrozil in middle-aged men with dyslipidemia. Safety of treatment, changes in risk factors, and incidence of coronary heart disease.
    Frick MH, Elo O, Haapa K, Heinonen OP, Heinsalmi P, Helo P, Huttunen JK, Kaitaniemi P, Koskinen P, Manninen V.
    N Engl J Med; 1987 Nov 12; 317(20):1237-45. PubMed ID: 3313041
    [Abstract] [Full Text] [Related]

  • 40. DEAE-Dextran in the treatment of primary hypercholesterolemia and/or hypercholesterolemia combined with hypertriglyceridemia. A multicentric randomized study on the efficacy of DEAE-Dextran compared with Cholestyramine.
    Fedele F.
    Clin Ter; 2003 Nov 12; 154(4):231-6. PubMed ID: 14618939
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 27.